Cargando…

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales:	Saad-Hossne, Rogerio, De Sibia, Carina De Fatima, Baima, Julio Pnheiro, Sassaki, Ligia Yukie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987516/ https://www.ncbi.nlm.nih.gov/pubmed/29786058 http://dx.doi.org/10.4103/0366-6999.232794

Ejemplares similares

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Inflammatory bowel disease epidemiology in São Paulo State, Brazil
por: Gasparini, Rodrigo Galhardi, et al.
Publicado: (2018)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
por: Takamune, Debora Mayumi, et al.
Publicado: (2022)

Clinical and Psychological Factors Associated with Addiction and Compensatory Use of Facebook Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study
por: Cury, Giovana Signorelli Astolfi, et al.
Publicado: (2022)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Immune Thrombocytopenic Purpura as an Extraintestinal Manifestation in a Patient with Ulcerative Colitis
por: de Medeiros Dutra, Renata, et al.
Publicado: (2022)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Small Intestinal Hemangioma: A Case Report
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2021)

MicroRNA expression in inflammatory bowel disease-associated colorectal cancer
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021)

Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease
por: Rocha, Thiara Barcelos, et al.
Publicado: (2021)

Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask
por: Perez de Arce, Edith, et al.
Publicado: (2021)

Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2023)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
por: Biondi, Robertha Baccaro, et al.
Publicado: (2020)

Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
por: Cassol, Ornella Sari, et al.
Publicado: (2022)

Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020
por: Martins, Adalberta Lima, et al.
Publicado: (2023)

Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
por: Hussain, Badrudeen M, et al.
Publicado: (2006)

Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020
por: Sassaki, Ligia Yukie, et al.
Publicado: (2023)

The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis
por: Aldana, Isabella, et al.
Publicado: (2022)

Cutaneous Involvement in Hodgkin Lymphoma: A Rare Case Report
por: Saavedra-Portales, Stephanie, et al.
Publicado: (2022)

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
por: Abeykoon, Jithma P., et al.
Publicado: (2019)

Fecal microbiota transplantation in refractory ulcerative colitis – a case report
por: Moutinho, B. D., et al.
Publicado: (2019)

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
por: Alkhateeb, Hassan B., et al.
Publicado: (2022)

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma
por: Mata, Elena, et al.
Publicado: (2019)

A Rare Case Report of Photosensitivity in Non-Hodgkin’S Lymphoma Treated with Lenalidomide
por: Soni, Rajesh K, et al.
Publicado: (2020)

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
por: Bari, Alessia, et al.
Publicado: (2016)

Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress
por: Liu, Shu-Zhong, et al.
Publicado: (2018)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

Incorporation of Ruxolitinib in the Management of Refractory/Relapsed Hodgkin Lymphoma: Where Do We Stand?
por: Al Sharie, Ahmed H., et al.
Publicado: (2023)

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
por: de Souza, Letícia Rodrigues, et al.
Publicado: (2023)

Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians
por: Friedman, Daphne R., et al.
Publicado: (2010)

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
por: Mangano, Chiara, et al.
Publicado: (2019)

Prolonged and recurrent hypoglycemia induced by trimethoprim-sulfamethoxazole in a Hodgkin lymphoma patient with Pneumocystis carinii pneumonia
por: Wang, Bing-Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kteb28gpj840p19ag9nh9605bv